Streamlined Access to Proven Precision Care Solutions to Help
Improve Resident Care
HOUSTON, Feb. 19,
2025 /PRNewswire/ -- AccessDx Laboratory, a
nationwide provider of precision medicine and diagnostics
solutions, today announced its expanded integration with
PointClickCare, a leading healthcare technology platform enabling
meaningful care collaboration and real-time patient insights. This
integration allows for the seamless delivery of pharmacogenomic
(PGx) risk assessments, advanced diagnostic test results, and
ongoing PGx monitoring, empowering them to deliver better and more
personalized resident care, allowing providers to quickly and
easily identify potentially dangerous drug-gene interactions for
their residents.
"We're pleased to announce our integration into PointClickCare's
solution that helps to enable both access and efficient use of
precision medicine solutions that benefit LTPAC providers and
residents nationwide," said Bryon Cipriani, CEO, AccessDx
Laboratory. "This integration with PointClickCare further
highlights our combined interests in meeting the needs of providers
and care organizations to help empower actionable, high-utility
precision medicine efforts."
AccessDx Laboratory's integration with PointClickCare directly
aligns with AccessDx Laboratory's mission to enable providers to
effectively apply the practical benefits of precision insights
within their care workflows, while ensuring the prescription of
safer and more effective medications for entire patient
populations. In a multi-facility analysis, the PointClickCare
integration allowed ten facilities to identify and address 77% of
their residents who were found to be at risk for severe or moderate
drug-gene interactions. This integration incorporates resident
medications as they are updated in the system, helping clinicians
who participate in the AccessDx Laboratory Risk Mitigation for
Seniors Program to utilize real-time PGx insights as part of their
overall care protocol.
"Our Marketplace Partners provide world-class technology and
share our deep commitment to ensuring our customers have access to
the most powerful, efficient, and effective solutions," said
Mike Boesveld, Director, Marketplace
Strategy, PointClickCare. "We are excited to integrate with
AccessDx Laboratory to jointly help our mutual clients manage
the complex challenges of long-term and post-acute care."
To learn more about AccessDx Laboratory's integration with
PointClickCare, contact connect@accessdxlab.com, learn more on
PointClickCare's Marketplace, or call 888-958-2298.
About AccessDx
Laboratory
AccessDx Laboratory is a
CLIA-certified, CAP-accredited, and NYSDOH-approved diagnostic
laboratory dedicated to providing clinical insights that help
improve patient outcomes. AccessDx solutions include
pharmacogenomics (PGx) testing, cancer genomic (CGX) testing,
infectious disease testing, and a wide range of clinical laboratory
research, development, and consultancy services. With demonstrated
commitments to clinical and analytical excellence, turnaround time,
and high-throughput operations and support infrastructure, millions
of AccessDx Laboratory tests have been trusted by thousands of
health systems, care providers, employer groups, and municipalities
nationwide. To learn more, visit www.accessdxlab.com.
Media Contact
Karina
Stabile
Senior Account Executive, Aria Marketing for AccessDx
Laboratory
617-833-5702
390296@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accessdx-laboratory-announces-integration-with-pointclickcare-302379183.html
SOURCE AccessDx Laboratory
